China Approves Clinical Trial Application for Grand Pharmaceutical's Urological Tumor Medication
05:39 AM EDT, 09/29/2022 (MT Newswires) -- China's medical products regulator approved the clinical trial application for Grand Pharmaceutical Group's (HKG:0512) TLX250-CDx medication, according to a
Broad Pharmaceutical: interim report 2022
We Think Grand Pharmaceutical Group (HKG:512) Can Stay On Top Of Its Debt
Warren Buffett famously said, 'Volatility is far from synonymous with risk.' So it might be obvious that you need to consider debt, when you think about how risky any given stock is, because too much
Is Grand Pharmaceutical Group Limited's (HKG:512) Stock's Recent Performance A Reflection Of Its Financial Health?
Most readers would already know that Grand Pharmaceutical Group's (HKG:512) stock increased by 4.6% over the past three months. Given its impressive performance, we decided to study the company's ke
Broad Pharmaceutical: announcement of interim results in 2022
Should You Be Adding Grand Pharmaceutical Group (HKG:512) To Your Watchlist Today?
For beginners, it can seem like a good idea (and an exciting prospect) to buy a company that tells a good story to investors, even if it currently lacks a track record of revenue and profit. But as P
Grand Pharma Sees Bigger H1 Profit on Telix Investment Gains
08:04 AM EDT, 08/08/2022 (MT Newswires) -- Grand Pharmaceutical Group (HKG:0512) is expecting a higher profit for the first half of the year due to its investment in Telix Pharmaceuticals (ASX:TLX).
Grand Pharmaceutical to Acquire Hubei Provincial Bafeng Pharmaceuticals
04:40 AM EDT, 08/08/2022 (MT Newswires) -- Grand Pharmaceutical Group (HKG:0512) will acquire 100% equity interests in Hubei Provincial Bafeng Pharmaceuticals and Chemicals Share for 270 million yuan
Broad Pharmaceutical: profit Forecast
Broad Pharmaceutical: the date of the board of directors